NCT01324726View on ClinicalTrials.gov

Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

April 30, 2015

Conditions
Escherichia Coli InfectionsKlebsiella Pneumonia
Trial Locations (1)

1107 2020

American University of Beirut Medical Center, Beirut

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

American University of Beirut Medical Center

OTHER

NCT01324726 - Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms | Biotech Hunter | Biotech Hunter